Early versus late parenteral nutrition in ICU patients: cost analysis of the EPaNIC trial
Critical Care, 06/12/2012Vanderheyden S et al.
The increased costs by Early–parenteral nutrition (PN) were mainly pharmacy–related and explained by higher expenditures for PN and anti–infective agents. The use of Early–PN in critically ill patients can thus not be recommended for both clinical (no benefit) and cost–related reasons.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.